Neuromodulation Is Now The Mainstream Therapy For Chronic Depression

read ( words)

The cover of the March 7, 2005 issue of Business Week titled REWIRING THE HUMAN BODY, describes how neuromodulation brings new hope to the four million desperate patients in the United States who suffer from the debilitating disease of chronic or treatment-resistant depression.

The neuromodulation industry is just in its infancy and could double over the next several years as doctors are thrilled by this vision of the body electric. Why these implantable devices work are a bit of a mystery, but the potential upside is great. Unlike most antidepressants, these implants produce few side effects and are aimed at patients that currently have no alternative therapies that adequately treat their depression.

Cyberonics Inc., the manufacturer of the vagus nerve stimulator, was listed as the leading company in the field of neuromodulation. The vagus nerve stimulator has been used to treat pharmaco-resistant epilepsy since 1997, now the FDA has approved the identical procedure to treat depression. This is wonderful news for the millions of desperate patients( and their families) who have been endlessly searching for an answer to their incurable disease.

Learn more about this remarkable device at You can keep up-to-date on all of the latest developments about this remarkable device. For more detailed information, there is an invaluable book available on the site:

Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression

The book gives the reader everything they need to know the vagus nerve stimulation therapy for depression. The book is also available on

Rate this article
Current Rating 0 stars (0 ratings)
Click the star above that marks your rating